207 related articles for article (PubMed ID: 31500466)
1. Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis.
Colas RA; Nhat LTH; Thuong NTT; Gómez EA; Ly L; Thanh HH; Mai NTH; Phu NH; Thwaites GE; Dalli J
FASEB J; 2019 Nov; 33(11):13028-13039. PubMed ID: 31500466
[TBL] [Abstract][Full Text] [Related]
2. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults.
Mai NTH; Dobbs N; Phu NH; Colas RA; Thao LTP; Thuong NTT; Nghia HDT; Hanh NHH; Hang NT; Heemskerk AD; Day JN; Ly L; Thu DDA; Merson L; Kestelyn E; Wolbers M; Geskus R; Summers D; Chau NVV; Dalli J; Thwaites GE
Elife; 2018 Feb; 7():. PubMed ID: 29482717
[TBL] [Abstract][Full Text] [Related]
3. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
Heemskerk D; Day J; Chau TT; Dung NH; Yen NT; Bang ND; Merson L; Olliaro P; Pouplin T; Caws M; Wolbers M; Farrar J
Trials; 2011 Feb; 12():25. PubMed ID: 21288325
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment Cerebrospinal Fluid Bacterial Load Correlates With Inflammatory Response and Predicts Neurological Events During Tuberculous Meningitis Treatment.
Thuong NTT; Vinh DN; Hai HT; Thu DDA; Nhat LTH; Heemskerk D; Bang ND; Caws M; Mai NTH; Thwaites GE
J Infect Dis; 2019 Feb; 219(6):986-995. PubMed ID: 30299487
[TBL] [Abstract][Full Text] [Related]
5. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome.
Marais S; Meintjes G; Pepper DJ; Dodd LE; Schutz C; Ismail Z; Wilkinson KA; Wilkinson RJ
Clin Infect Dis; 2013 Feb; 56(3):450-60. PubMed ID: 23097584
[TBL] [Abstract][Full Text] [Related]
6. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study.
Thwaites GE; Macmullen-Price J; Tran TH; Pham PM; Nguyen TD; Simmons CP; White NJ; Tran TH; Summers D; Farrar JJ
Lancet Neurol; 2007 Mar; 6(3):230-6. PubMed ID: 17303529
[TBL] [Abstract][Full Text] [Related]
7. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses.
Simmons CP; Thwaites GE; Quyen NT; Chau TT; Mai PP; Dung NT; Stepniewska K; White NJ; Hien TT; Farrar J
J Immunol; 2005 Jul; 175(1):579-90. PubMed ID: 15972695
[TBL] [Abstract][Full Text] [Related]
8. Changes in cerebrospinal fluid cytokine expression in tuberculous meningitis patients with treatment.
Kashyap RS; Deshpande PS; Ramteke SR; Panchbhai MS; Purohit HJ; Taori GM; Daginawala HF
Neuroimmunomodulation; 2010; 17(5):333-9. PubMed ID: 20407285
[TBL] [Abstract][Full Text] [Related]
9. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model.
Kumar R; Kolloli A; Singh P; Vinnard C; Kaplan G; Subbian S
Front Cell Infect Microbiol; 2019; 9():450. PubMed ID: 32010638
[TBL] [Abstract][Full Text] [Related]
11. Does adjunctive corticosteroid and aspirin therapy improve the outcome of tuberculous meningitis?
Misra UK; Kalita J; Sagar B; Bhoi SK
Neurol India; 2018; 66(6):1672-1677. PubMed ID: 30504561
[TBL] [Abstract][Full Text] [Related]
12. 15-Epi-LXA
Dakin SG; Colas RA; Newton J; Gwilym S; Jones N; Reid HAB; Wood S; Appleton L; Wheway K; Watkins B; Dalli J; Carr AJ
FASEB J; 2019 Jul; 33(7):8043-8054. PubMed ID: 30916999
[TBL] [Abstract][Full Text] [Related]
13. Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial.
Maitre T; Bonnet M; Calmy A; Raberahona M; Rakotoarivelo RA; Rakotosamimanana N; Ambrosioni J; Miró JM; Debeaudrap P; Muzoora C; Davis A; Meintjes G; Wasserman S; Wilkinson R; Eholié S; Nogbou FE; Calvo-Cortes MC; Chazallon C; Machault V; Anglaret X; Bonnet F
Trials; 2022 Nov; 23(1):928. PubMed ID: 36348453
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of inflammatory mediators in brain extracellular fluid in paediatric TBM.
Loxton NW; Rohlwink UK; Tshavhungwe M; Dlamini L; Shey M; Enslin N; Figaji A
PLoS One; 2021; 16(3):e0246997. PubMed ID: 33711020
[TBL] [Abstract][Full Text] [Related]
15. NELL2 as a potential marker of outcome in the cerebrospinal fluid of patients with tuberculous meningitis: preliminary results from a single-center observational study.
Chen J; Wu J; Luo Y; Huang N
Eur J Med Res; 2022 Dec; 27(1):281. PubMed ID: 36494747
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.
Thuong NTT; Heemskerk D; Tram TTB; Thao LTP; Ramakrishnan L; Ha VTN; Bang ND; Chau TTH; Lan NH; Caws M; Dunstan SJ; Chau NVV; Wolbers M; Mai NTH; Thwaites GE
J Infect Dis; 2017 Apr; 215(7):1020-1028. PubMed ID: 28419368
[TBL] [Abstract][Full Text] [Related]
17. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial.
Misra UK; Kalita J; Nair PP
J Neurol Sci; 2010 Jun; 293(1-2):12-7. PubMed ID: 20421121
[TBL] [Abstract][Full Text] [Related]
18. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.
Thwaites G; Fisher M; Hemingway C; Scott G; Solomon T; Innes J;
J Infect; 2009 Sep; 59(3):167-87. PubMed ID: 19643501
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis.
van der Flier M; Hoppenreijs S; van Rensburg AJ; Ruyken M; Kolk AH; Springer P; Hoepelman AI; Geelen SP; Kimpen JL; Schoeman JF
Pediatr Infect Dis J; 2004 Jul; 23(7):608-13. PubMed ID: 15247597
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cerebrospinal fluid adenosine deaminase activity for the differential diagnosis of tuberculous and nontuberculous meningitis.
Sun Q; Sha W; Xiao HP; Tian Q; Zhu H
Am J Med Sci; 2012 Aug; 344(2):116-21. PubMed ID: 22104430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
